glycerol has been researched along with transforming growth factor beta in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Croatt, AJ; Grande, JP; Haggard, JJ; Nath, KA | 1 |
| Arai, M; Fushiki, T; Inoue, K; Matsumura, S; Yamazaki, H | 1 |
| Chai, YB; Chen, NC; Chen, SM; Li, Y; Pu, Q; Zhao, ZL | 1 |
| Haas, NP; Kadow-Romacker, A; Schmidmaier, G; Wildemann, B | 1 |
| Ghodasra, JH; Glicksman, ZS; Hsu, EL; Hsu, WK; Polavarapu, M; Riaz, R; Roc, GC; Stock, SR | 1 |
| Brolinson, PG; Docheva, D; Ekwueme, EC; Fernandes, HAM; Freeman, JW; Mohiuddin, M; Yarborough, JA | 1 |
| Arc-Chagnaud, C; Brioche, T; Chopard, A; Pagano, AF; Py, G | 1 |
| Badawi, AM; Elrehany, M; Maher, SA; Mansour, HF; Mohamad, SA; Safwat, MA | 1 |
| Chen, H; Chen, WC; Su, VY; Wu, HH; Yang, KY; Yu, WK | 1 |
| Andersson, DP; Arner, P; Hofwimmer, K; Laurencikiene, J; Massier, L; Subramanian, N; Tavira, B | 1 |
10 other study(ies) available for glycerol and transforming growth factor beta
| Article | Year |
|---|---|
Renal response to repetitive exposure to heme proteins: chronic injury induced by an acute insult.
Topics: Acute Disease; Animals; Chemokine CCL2; Chronic Disease; Collagen; Creatinine; Glycerol; Hemeproteins; Injections, Intramuscular; Kidney; Kidney Diseases; Oxidative Stress; Rats; Transforming Growth Factor beta | 2000 |
Intracranial administration of transforming growth factor-beta3 increases fat oxidation in rats.
Topics: Animals; Blood; Cisterna Magna; Energy Metabolism; Fats; Glycerol; Hormones; Injections; Lipoprotein Lipase; Male; Motor Activity; Muscle, Skeletal; Oxidation-Reduction; Oxygen Consumption; Pulmonary Gas Exchange; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Transforming Growth Factor beta3 | 2002 |
[High density fed-batch culture of Escherichia coli DH5 alpha/pDH-B2m with DO feed-back control of nutrient feeding].
Topics: Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Culture Media; Escherichia coli; Fermentation; Glycerol; Recombinant Proteins; Time Factors; Transforming Growth Factor beta | 2002 |
Quantification of various growth factors in different demineralized bone matrix preparations.
Topics: Bone Matrix; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein 4; Bone Morphogenetic Proteins; Bone Substitutes; Bone Transplantation; Fibroblast Growth Factor 1; Glycerol; Growth Substances; Humans; In Vitro Techniques; Insulin-Like Growth Factor I; Materials Testing; Osteogenesis; Platelet-Derived Growth Factor; Transforming Growth Factor beta; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2007 |
Nanocomposite therapy as a more efficacious and less inflammatory alternative to bone morphogenetic protein-2 in a rodent arthrodesis model.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Substitutes; Collagen; Disease Models, Animal; Durapatite; Fracture Healing; Glycerol; Humans; Lumbar Vertebrae; Nanocomposites; Osteitis; Postoperative Complications; Pseudarthrosis; Rats; Rats, Nude; Recombinant Proteins; Spinal Diseases; Spinal Fusion; Transforming Growth Factor beta; X-Ray Microtomography | 2011 |
Prolotherapy Induces an Inflammatory Response in Human Tenocytes In Vitro.
Topics: Achilles Tendon; Cell Line; Cell Movement; Cell Proliferation; Glucose; Glycerol; Hamstring Muscles; Humans; Phenol; Protective Agents; RNA; Tenocytes; Transforming Growth Factor beta | 2017 |
Muscle Resting and TGF-β Inhibitor Treatment Prevent Fatty Infiltration Following Skeletal Muscle Injury.
Topics: Adipose Tissue; Animals; Apoptosis; Decorin; Female; Glycerol; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Muscular Diseases; Physical Conditioning, Animal; Receptor, Platelet-Derived Growth Factor alpha; Stem Cells; Transforming Growth Factor beta | 2019 |
A novel nasal co-loaded loratadine and sulpiride nanoemulsion with improved downregulation of TNF-α, TGF-β and IL-1 in rabbit models of ovalbumin-induced allergic rhinitis.
Topics: Administration, Intranasal; Animals; Calorimetry, Differential Scanning; Disease Models, Animal; Dopamine Antagonists; Drug Combinations; Drug Liberation; Emulsions; Glycerol; Glycine max; Histamine H1 Antagonists, Non-Sedating; In Vitro Techniques; Interleukin-1; Lecithins; Loratadine; Nanostructures; Nasal Mucosa; Olive Oil; Ovalbumin; Paranasal Sinuses; Polysorbates; Rabbits; Rhinitis, Allergic; Sodium Cholate; Spectroscopy, Fourier Transform Infrared; Sulpiride; Surface-Active Agents; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2021 |
The main e-cigarette component vegetable glycerin enhances neutrophil migration and fibrosis in endotoxin-induced lung injury via p38 MAPK activation.
Topics: Acute Lung Injury; Animals; Electronic Nicotine Delivery Systems; Fibrosis; Glycerol; Integrin alpha4beta1; Lipopolysaccharides; Lung; Mice; Neutrophils; p38 Mitogen-Activated Protein Kinases; Transforming Growth Factor beta; Vascular Cell Adhesion Molecule-1 | 2023 |
Adipose tissue specific CCL18 associates with cardiometabolic diseases in non-obese individuals implicating CD4
Topics: Adipose Tissue; Adipose Tissue, White; Cardiovascular Diseases; CD4-Positive T-Lymphocytes; Chemokines, CC; Cytokines; Diabetes Mellitus, Type 2; Glycerol; Humans; Obesity; T-Lymphocytes; Transforming Growth Factor beta | 2023 |